A Study of Accelerated Guideline-Directed Medical Therapy for Heart Failure

CompletedOBSERVATIONAL
Enrollment

342

Participants

Timeline

Start Date

March 3, 2024

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions
Heart Failure
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY